NOW Foods   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Bloomingdale IL United States (1968)
Status: No NME R&D (1968)

Organization Overview

First Clinical Trial
2013
NCT02143817
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

NOW Foods

Active Ingredients

Drugs in Phase 3 Trials (1)

nicotinamide (2 trials)

Drugs in Phase 2 Trials (1)

hyaluronic acid (1 trial)

Drugs in Phase 1 Trials (3)

gad-alum (1 trial)

maltodextrin (1 trial)

piperidic acid (1 trial)

Drugs in Other Trials (3)

betaine (1 trial)

branched chain amino acids (1 trial)

citrulline (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthralgia (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Skin Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 8